Elena Eckroth

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

Richard H. Ko, Lingyun Ji, Phillip Barnette et al. · Journal of Clinical Oncology · 2009 · 273 citations · Full text

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Yoav H. Messinger, Paul S. Gaynon, Richard Sposto et al. · Blood · 2012 · 203 citations · Full text

Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium

Yoav H. Messinger, Paul S. Gaynon, Elizabeth A. Raetz et al. · Pediatric Blood & Cancer · 2010 · 112 citations · Full text

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Matthew F. Gorman, Lingyun Ji, Richard H. Ko et al. · Pediatric Blood & Cancer · 2010 · 111 citations

A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Todd M. Cooper, Jeannette Cassar, Elena Eckroth et al. · Clinical Cancer Research · 2016 · 72 citations